Description
This book presents a comprehensive introduction to innovative nonantibiotic therapies for Helicobacter pylori infection. It examines advanced treatment strategies, including nanomaterials, immunotherapy, probiotics, traditional Chinese medicine, natural products, phage therapy, antibacterial peptides, gene editing technology, and potassium-competitive acid blockers, connects cutting-edge research and clinical applications. With contributions from leading experts, the book provides a multidisciplinary perspective on managing H. pylori and highlights promising alternatives to conventional antibiotic-based regimens. It provides valuable information for graduate students, researchers and clinicians who are interested in alternative treatment strategies, addressing antibiotic resistance and improving patient outcomes.
Table of Contents
Chapter 1. History and Definition of H. pylori.- Chapter 2. Biological Characteristics of H. pylori.- Chapter 3. Epidemiology of H. pylori Infection.- Chapter 4. Mechanisms of H. pylori Colonization and Pathogenesis.- Chapter 5. The Role of H. pylori in Gastric Carcinogenesis.- Chapter 6. Managing H. pylori in the Era of Antibiotic Resistance.- Chapter 7. Non-Responsive Nanomaterials.- Chapter 8. Externally Responsive Nanomaterials.- Chapter 9. Internally Environment-Responsive Nanomaterials.- Chapter 10. Multi-Stimuli-Responsive Nanomaterials.- Chapter 11. Antimicrobial Mechanisms of Nanomaterials.- Chapter 12. Host Immune Response to H. pylori Infection.- chapter 13. Immune Evasion Mechanisms of H. pylori.- Chapter 14. Immunotherapeutic Strategies against H. pylori.- Chapter 15. Clinical Research and Challenges of Immunotherapy.- Chapter 16. The Future of Immunotherapy.- Chapter 17. Probiotic Mechanisms in H. pylori Infection.- Chapter 18. Probiotics in H. pylori Adjunctive Therapy.- Chapter 19. The Future of Probiotic Therapy.- Chapter 20. The Theoretical Basis of TCM for Treating H. pylori.- Chapter 21. TCM Pharmacology and Clinical Practice in H. pylori.- Chapter 22. Natural Product Therapy against H. pylori.- Chapter 23. Phage Therapy for H. pylori.- Chapter 24. Antibacterial Peptides against H. pylori.- Chapter 25. Gene Editing Technology against H. pylori.- Chapter 26. Potassium-Competitive Acid Blockers against H. pylori.- Chapter 27. Non-Antibiotic Clinical Trials for H. pylori.- Chapter 28. Policy and Market Prospects for Non-Antibiotic Therapy.- Chapter 29. The Future of Non-Antibiotic Therapy.



